Skip to main content

Envarsus

NDC 68992-3075 · Veloxis Pharmaceuticals, Inc

Generic nameTacrolimus
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)TACROLIMUS
Strength.75 mg/1
Pharmacologic classCalcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]
Marketing categoryNDA

Packages

68992-3075-1 — 1 POUCH in 1 CARTON (68992-3075-1) / 1 BOTTLE in 1 POUCH / 100 TABLET, EXTENDED RELEASE in 1 BOTTLE

68992-3075-3 — 1 POUCH in 1 CARTON (68992-3075-3) / 1 BOTTLE, PLASTIC in 1 POUCH / 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC

Billed under HCPCS

J7503 — Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg Medicare Part B payment limit (ASP + 6%): $1.86

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68254-5004 — Tacrolimus, 68254-5005 — Tacrolimus, 68254-5006 — Tacrolimus, 68462-534 — Tacrolimus, 68462-685 — tacrolimus, 68462-686 — tacrolimus, 68462-687 — tacrolimus, 68462-881 — Tacrolimus, 68992-3010 — Tacrolimus, 68992-3040 — Tacrolimus, 69238-2780 — Tacrolimus, 69238-2781 — Tacrolimus, 69238-2782 — Tacrolimus, 70377-014 — Tacrolimus, 70377-015 — Tacrolimus, 70377-016 — Tacrolimus, 71335-2189 — Tacrolimus, 71432-2001 — tacrolimus extended-release capsules, 71432-2002 — tacrolimus extended-release capsules, 71432-2003 — tacrolimus extended-release capsules, +83 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.